Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 9.48 is 22% below its 4-year average of 12.16, around the middle of its 4-year range (0.00–22.15).
As of the fiscal period ended Tuesday, June 30, 2026. 9.39% below its 12-month average of 10.46.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.48.
QUICK RATIO (ACID-TEST)
9.48
QUICK RATIO (ACID-TEST) AVG TTM
10.46
QUICK RATIO (ACID-TEST) AVG 3Y
14.29
QUICK RATIO (ACID-TEST) AVG 5Y
12.16
QUICK RATIO (ACID-TEST) AVG 10Y
12.71
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-9.39%
CURRENT VS 3Y AVG
-33.63%
CURRENT VS 5Y AVG
-22.01%
CURRENT VS 10Y AVG
-25.40%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.20
median of 772 covered companies
CURRENT VS SECTOR MEDIAN
+196.74%
vs the sector median at left
Boundless Bio, Inc.
Market Cap
$57.54M
Quick Ratio (Acid-Test)
9.48
TTM Avg
10.46
3Y Avg
14.29
5Y Avg
12.16
Market Cap
$56.98M
Quick Ratio (Acid-Test)
2.43
TTM Avg
1.42
3Y Avg
0.93
5Y Avg
1.83
Market Cap
$58.57M
Quick Ratio (Acid-Test)
3.15
TTM Avg
4.21
3Y Avg
4.66
5Y Avg
4.26
Market Cap
$58.79M
Quick Ratio (Acid-Test)
1.23
TTM Avg
0.89
3Y Avg
0.93
5Y Avg
1.06
Market Cap
$59.56M
Quick Ratio (Acid-Test)
0.57
TTM Avg
2.81
3Y Avg
4.44
5Y Avg
7.47
Market Cap
$59.71M
Quick Ratio (Acid-Test)
1.35
TTM Avg
1.97
3Y Avg
5.50
5Y Avg
8.52
Market Cap
$60.71M
Quick Ratio (Acid-Test)
6.71
TTM Avg
8.38
3Y Avg
9.61
5Y Avg
10.03
Market Cap
$54.10M
Quick Ratio (Acid-Test)
0.85
TTM Avg
0.73
3Y Avg
1.25
5Y Avg
1.77
Market Cap
$60.99M
Quick Ratio (Acid-Test)
2.37
TTM Avg
7.60
3Y Avg
7.51
5Y Avg
12.19
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | $57.54M | 9.48 | 10.46 | 14.29 | 12.16 |
| OKYO Pharma Limited (OKYO)vs › | $56.98M | 2.43 | 1.42 | 0.93 | 1.83 |
| Fractyl Health, Inc. (GUTS)vs › | $58.57M | 3.15 | 4.21 | 4.66 | 4.26 |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.79M | 1.23 | 0.89 | 0.93 | 1.06 |
| PDS Biotechnology Corporation (PDSB)vs › | $59.56M | 0.57 | 2.81 | 4.44 | 7.47 |
| Oncolytics Biotech Inc. (ONCY)vs › | $59.71M | 1.35 | 1.97 | 5.50 | 8.52 |
| Adicet Bio, Inc. (ACET)vs › | $60.71M | 6.71 | 8.38 | 9.61 | 10.03 |
| Spectral AI, Inc. (MDAI)vs › | $54.10M | 0.85 | 0.73 | 1.25 | 1.77 |
| Connect Biopharma Holdings Limited (CNTB)vs › | $60.99M | 2.37 | 7.60 | 7.51 | 12.19 |
| Aldeyra The (ALDX)vs › | $53.98M | 4.91 | 4.08 | 6.65 | 8.84 |
Quick Ratio
9.48
Excludes inventory
Current Ratio
9.48
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 9.48 |
| 2026-03-31 | 9.87 |
| 2025-12-31 | 8.74 |
| 2025-09-30 | 10.14 |
| 2025-06-30 | 14.08 |
| 2025-03-31 | 22.15 |
| 2024-12-31 | 18.98 |
| 2024-09-30 | 17.03 |
| 2024-06-30 | 20.45 |
| 2024-03-31 | 10.54 |
| 2023-12-31 | 13.27 |
| 2023-09-30 | 13.09 |
| 2023-06-30 | 17.90 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 8.80 |
| 2022-09-30 | 0.00 |
| 2019-09-30 | 12.79 |
| 2019-06-30 | 14.38 |
| 2019-03-31 | 14.29 |
| 2018-12-31 | 17.60 |
| 2018-09-30 | 14.83 |
| 2018-06-30 | 19.05 |
| 2018-03-31 | 20.43 |
| 2017-12-31 | 7.74 |
| 2017-09-30 | 12.04 |
| 2017-06-30 | 10.06 |
| 2017-03-31 | 9.87 |
| 2016-12-31 | 8.63 |
| 2016-09-30 | 12.35 |
